Public annual accounts

DR. SABINE VERGAUWEN financials

Name: DR. SABINE VERGAUWEN financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. SABINE VERGAUWEN, with comparable measures and links to available source documents.

Company overview

Registry number

0473819066

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DR. SABINE VERGAUWEN

2025 versus 2024

Operating line: €352,514
EBITDA: €350,990
Total assets: €2,175,068
Equity: €2,039,806

EBITDA margin +99.6% · Equity ratio +93.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€352,514	€350,990	€2,175,068	€2,039,806	-
202431 Dec 2024	€347,739	€346,261	€1,902,446	€1,868,275	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€352,514

€350,990

€2,175,068

€2,039,806

202431 Dec 2024

€347,739

€346,261

€1,902,446

€1,868,275